No long-term evidence of hyporesponsiveness following the use of pneumococcal conjugate vaccine in children previously immunised with pneumococcal polysaccharide vaccine

BACKGROUND: A randomised controlled trial in Fiji examined the immunogenicity and impact on nasopharyngeal carriage following 0, 1, 2 or 3 doses of pneumococcal conjugate vaccine (PCV7) in infancy followed by 23-valent pneumococcal polysaccharide (23vPPV) vaccine at 12 months of age. At 18 months of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Allergy Clin Immunol
Glavni autori: Licciardi, Paul V, Toh, Zheng Quan, Clutterbuck, Elizabeth A, Balloch, Anne, Marimla, Rachel A, Tikkanen, Leena, Lamb, Karen E, Bright, Kathryn J, Rabuatoka, Uraia, Tikoduadua, Lisi, Boelsen, Laura K, Dunne, Eileen M, Satzke, Catherine, Cheung, Yin Bun, Pollard, Andrew J, Russell, Fiona M, Mulholland, Edward K
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899320/
https://ncbi.nlm.nih.gov/pubmed/26825000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2015.12.1303
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items